One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Authors: Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Associate Editor., Feldman T; NorthShore University Health System, Evanston Hospital, Evanston, Illinois., Ricciardi MJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Kahwash R; Ohio State University Wexner Medical Center, Columbus., Lilly S; Ohio State University Wexner Medical Center, Columbus., Litwin S; Medical University of South Carolina, Charleston., Nielsen CD; Medical University of South Carolina, Charleston.; Ralph H. Johnson VA Medical Center, Charleston, South Carolina., van der Harst P; University Medical Center Groningen, Groningen, the Netherlands., Hoendermis E; University Medical Center Groningen, Groningen, the Netherlands., Penicka M; Cardiovascular Center Aalst, Aalst, Belgium., Bartunek J; Cardiovascular Center Aalst, Aalst, Belgium., Fail PS; Cardiovascular Institute of the South, Houma, Louisiana., Kaye DM; Alfred Hospital, Melbourne, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Walton A; Alfred Hospital, Melbourne, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Petrie MC; University of Glasgow, Glasgow, United Kingdom., Walker N; University of Glasgow, Glasgow, United Kingdom., Basuray A; OhioHealth Heart and Vascular-Riverside Methodist Hospital, Columbus., Yakubov S; OhioHealth Heart and Vascular-Riverside Methodist Hospital, Columbus., Hummel SL; University of Michigan, Ann Arbor., Chetcuti S; University of Michigan, Ann Arbor.; VA Ann Arbor, Ann Arbor, Michigan., Forde-McLean R; Hospital of the University of Pennsylvania, Philadelphia., Herrmann HC; Hospital of the University of Pennsylvania, Philadelphia., Burkhoff D; Cardiovascular Research Foundation, New York, New York., Massaro JM; Boston University School of Public Health, Boston, Massachusetts., Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health & Well-Being, University of Glasgow, Glasgow, United Kingdom.; National Heart & Lung Institute, Imperial College, Kensington, London, United Kingdom., Mauri L; Baim Institute of Clinical Research, Boston, Massachusetts.; Harvard University, Boston, Massachusetts.; Now with Medtronic Inc, Boston, Massachusetts.
Source: JAMA cardiology [JAMA Cardiol] 2018 Oct 01; Vol. 3 (10), pp. 968-977.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2380-6591
DOI:10.1001/jamacardio.2018.2936